Jim McMillan v. InvenSense, Inc. et al
Filing
101
ORDER DISMISSING CASE. Signed by Judge James Donato on 4/12/2017. (jdlc2S, COURT STAFF) (Filed on 4/12/2017)
1
2
3
4
UNITED STATES DISTRICT COURT
5
NORTHERN DISTRICT OF CALIFORNIA
6
7
IN RE INVENSENSE, INC. SECURITIES
LITIGATION.
8
Case No. 15-cv-00084-JD
ORDER DISMISSING CASE
9
Re: Dkt. No. 80
10
United States District Court
Northern District of California
11
12
In this securities fraud class action, defendants challenge plaintiff’s first amended
13
14
complaint for failing to state actionable claims. Dkt. No. 80. The complaint is dismissed with
15
prejudice and the case is ordered closed.
DISCUSSION
16
17
I.
INVENTORY CLAIMS (STATEMENT NOS. 1-3)
18
The Court dismissed plaintiff’s first effort to state inventory-related claims for failing to
19
plead falsity adequately. See Dkt. No. 78. Specifically, plaintiff did not state with particularity
20
the facts on which plaintiff’s information and belief were formed. Id. at 6-7 (citing 15 U.S.C.
21
§ 78u-4(b)(1)). The Court expressly advised plaintiff that, while a confidential witness or
22
informant is by no means a mandatory factor, it needed “to identify some source for how it knows
23
of the key, very detailed factual allegations in its complaint that support its theory of falsity, e.g.,
24
that ‘by the end of June 2013, InvenSense had built up an inventory of approximately 20 million
25
3-axis MEMS chips that were specifically for the iPhone 5S and 5C’; or that these chips, which
26
had an ‘approximate cost of $0.44 per chip’ became unsalable because, among other things, they
27
‘suffered from manufacturing yield problems and did not meet any high-volume customer’s
28
specifications.’” Id. at 7 (quoting Dkt. No. 62 ¶¶ 8, 58-60).
1
The inventory claims in the amended complaint again do not meet this basic pleading
2
obligation. The foundational factual allegation upon which these claims hinge is that the “excess
3
or obsolete” inventory InvenSense later had to write down in fact consisted of “20 million 3-axis
4
MEMS chips that had been manufactured for use in the iPhone 5S and 5C in the summer of 2013,
5
but never sold to Apple.” Dkt. No. 79 ¶ 47. There can be no question that without this fact, the
6
inventory claims cannot stand. See Dkt. No. 79-1 at 1-2 (explaining that the reason why Statement
7
Nos. 1-3 were false and misleading is because the later written-off inventory “was primarily
8
comprised of approximately 20 million chips leftover from the Apple design loss with the iPhone
9
5S and 5C” which the Company improperly failed to write off earlier).
Despite another chance to explain why or how it knows or believes this foundational fact
11
United States District Court
Northern District of California
10
to be true, plaintiff’s allegations remain materially unchanged. Plaintiff says paragraphs 48 to 50
12
of the amended complaint lay out the bases for its information and belief, see Dkt. No. 86 at 2-3,
13
but that is not the case. In Berson v. Applied Signal Technology, Inc., 527 F.3d 982 (9th Cir.
14
2008), an analogous foundational fact was the existence of four “stop-work orders.” Plaintiffs
15
alleged those orders made Applied Signal’s backlog reports misleading because the reports
16
included work Applied Signal was unlikely ever to perform because it “had been halted [by the
17
stop-work orders] and was likely to be lost forever.” Id. at 984. The circuit rejected the falsity
18
challenge because the complaint had “identifie[d] four confidential witnesses who worked for
19
Applied Signal and who allegedly will testify to the existence and effect of the stop-work orders.”
20
Id. at 985. These confidential witness employees were of a type where it was “entirely plausible”
21
that they “would know, or could reasonably deduce, that the company had suffered such
22
setbacks.” Id. The circuit expressly held that plaintiffs had “allege[d] the existence . . . of the
23
stop-work orders with particularity,” where for the second stop-work order, the complaint
24
contained statements by one of the confidential witnesses that “the order followed a ‘series’ of
25
client meetings where ‘management’ tried unsuccessfully to ‘negotiate away’ certain contract
26
requirements.” Id. at 987 & 988 n. 5. The circuit also observed that “a different confidential
27
witness will allegedly testify that the third stop-work order caused the company to reassign ‘50-75
28
employees,’ with the result that one of the company’s facilities became a ‘ghost town.’” Id.
2
The scant factual allegations here about the supposed existence of the 20 million 3-axis
2
MEMS chips are qualitative worlds apart from the allegations upheld in Berson. It is true that
3
plaintiff now makes a passing reference to a confidential witness. See Dkt. No. 79 ¶ 50 (“In
4
addition to the above sources, Lead Plaintiff’s allegations regarding InvenSense’s inventory of and
5
inability to sell the 20 million 3-axis MEMS chips that had been manufactured for use in the
6
iPhone 5S and 5C are based on and corroborated by investigative interviews with a former
7
InvenSense officer who has requested to remain anonymous.”). But this allegation is so sparse
8
and conclusory that it does not add materially to the soundness of the complaint. Cf. Zucco
9
Partners, LLC v. Digimarc Corp., 552 F.3d 981, 995 (9th Cir. 2009) (for complaint relying on
10
statements from confidential witnesses to satisfy PSLRA pleading requirements, confidential
11
United States District Court
Northern District of California
1
witness “must be described with sufficient particularity to establish their reliability and personal
12
knowledge”). Not only is the confidential witness barely described, the complaint does not offer
13
up any specific statements by the confidential witness at all.
14
The other allegations are also insufficient. Plaintiff has added citations to the Company’s
15
own SEC filings and a handful of third-party articles and reports. Dkt. No. 79 ¶¶ 48-49. But the
16
Company’s SEC filings did not reveal that its obsolete inventory consisted of 20 million 3-axis
17
MEMS chips -- if they had, there would be no securities fraud case at all. And the speculations of
18
some journalists and analysts along the same lines as plaintiff do not make them useful “sources”
19
for plaintiff’s claims. Allegations of this kind fail to meet the PSLRA’s requirement that falsity be
20
pled with particularity under 15 U.S.C. § 78u-4(b)(1). See Rubke v. Capitol Bancorp Ltd, 551
21
F.3d 1156, 1166 (9th Cir. 2009) (“Rubke has failed to reveal ‘the sources of her information’ with
22
regard to the telephone conversations, and has not otherwise described how she knows that Capitol
23
‘exhorted’ Pedisich to make the calls. Thus, she has not properly alleged the falsity of these
24
statements under the PSLRA.”) (internal citations omitted); Applestein v. Medivation, Inc., 561
25
Fed. Appx. 598, 600 (9th Cir. 2014) (“uncredited and speculative conclusions do not ‘provide an
26
adequate basis for believing that the defendants’ statements were false’”) (quoting Zucco Partners,
27
552 F.3d at 995); see also In re: FVC.com Sec. Litig., 32 Fed. Appx. 338, 340 (9th Cir. 2002)
28
(finding plaintiffs’ scienter allegations deficient where complaint contained nothing to suggest that
3
1
plaintiffs’ allegations were “based on anything other than mere speculation. That is precisely the
2
kind of allegation that the PSLRA is designed to defeat at the pleading stage.”).
3
II.
4
PRICING CLAIM (STATEMENT NO. 4)
The Court dismissed with prejudice plaintiff’s gross margin claims, see Dkt. No. 78 at 8-
5
12, and plaintiff has now turned to a pricing claim. See Dkt. No. 79-1 at 8, Statement No. 4
6
(identifying 7/29/14 statement by Krock on an earnings conference call: “But generally it’s about
7
the value of these sensor function [sic] in the market with the Gyro and integrated sensor attached.
8
So there’s no one customer with any particular window of pricing that’s relevant.”). Plaintiff says
9
that this statement was false and misleading because “[d]efendants lacked a reasonable basis to
assure investors that ASPs would be ‘consistent’ with prior quarters. Apple’s purchase order with
11
United States District Court
Northern District of California
10
InvenSense for at least 35 million 6-axis MEMS chips a quarter for its iPhone 6 and 6 Plus was at
12
heavily discounted prices that [sic] the Company’s margins on those chips would only be
13
approximately 40%.” Id.
14
But just reading those two columns side by side makes plain why this new statement does
15
not support a claim. “At the pleading stage, a complaint alleging claims under Section 10(b) and
16
Rule 10b-5 must not only meet the requirements of Rule 8, but must satisfy the heightened
17
pleading requirements of both Federal Rule of Civil Procedure 9(b) and the Private Securities
18
Litigation Reform Act (‘PSLRA’).” In re Rigel Pharm., Inc. Sec. Litig., 697 F.3d 869, 876 (9th
19
Cir. 2012). Under Rule 8, a complaint must allege “enough facts to state a claim to relief that is
20
plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). Rule 9(b) requires
21
“particularized allegations of the circumstances constituting fraud, including identifying the
22
statements at issue and setting forth what is false or misleading about the statement and why the
23
statements were false or misleading at the time they were made.” In re Rigel, 697 F.3d at 876.
24
And under the PSLRA, to properly allege falsity, a securities fraud complaint must “specify each
25
statement alleged to have been misleading [and] the reason or reasons why the statement is
26
misleading.” 15 U.S.C. § 78u-4(b)(1).
27
28
Plaintiff has not met any of these requirements for the new pricing claim because there is a
mismatch between the statement identified as false and misleading on the one hand, and the
4
1
reasons why plaintiff says the statement was false or misleading on the other. On its face, Krock’s
2
July 29, 2014 statement said nothing about “ASPs” or the “Company’s margins.” See Dkt.
3
No. 79-1 at 8. Moreover, reading the statement in its full context makes it even more clear that
4
Krock was discussing periods of time during which pricing could be negotiated, and not whether
5
there was or was not any particular customer whose band of pricing might be significant for the
6
Company’s overall financial outlook. See Dkt. No. 81-1, Ex. 1 at 21 (transcript of 7/29/2014
7
InvenSense earnings call, in which Krock discussed customers’ “unique schedules for negotiation
8
of pricing”).
Accordingly, for the new pricing claim, plaintiff has failed to plead falsity whether
9
measured under Rule 8, Rule 9(b) or the PSLRA.
11
United States District Court
Northern District of California
10
III.
SCIENTER AND 20(a) CLAIM
Because plaintiff has failed once again to sufficiently plead falsity as required by the
12
13
PSLRA, the Court need not reach the issue of scienter for plaintiff’s Section 10(b)/Rule 10b-5
14
claim. Furthermore, because plaintiff has not adequately pled a violation of Section 10(b),
15
plaintiff’s Section 20(a) “control person liability” claim must also be dismissed. See Oregon Pub.
16
Emps. Ret. Fund v. Apollo Group Inc., 774 F.3d 598, 610 (9th Cir. 2014).
17
IV.
LEAVE TO AMEND
Plaintiff has not requested a further opportunity to amend its complaint, see Dkt. No. 86,
18
19
and the Court sees no good reason to grant it at this stage of the case. As here, “where the plaintiff
20
has previously been granted leave to amend and has subsequently failed to add the requisite
21
particularity to its claims, the district court’s discretion to deny leave to amend is particularly
22
broad.” Zucco Partners, 552 F.3d at 1007 (internal quotations omitted). The fact that plaintiff
23
failed to correct the deficiencies the Court previously pointed out “is a strong indication that the
24
plaintiffs have no additional facts to plead.” Id. Because it is clear plaintiff has made its best case
25
and that best case is still wanting, the Court will not grant plaintiff a further opportunity to amend.
26
//
27
//
28
//
5
1
CONCLUSION
2
Plaintiff’s first amended complaint is dismissed with prejudice. The Clerk will enter
3
4
5
judgment and close the case.
IT IS SO ORDERED.
Dated: April 12, 2017
6
7
JAMES DONATO
United States District Judge
8
9
10
United States District Court
Northern District of California
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
6
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?